Standout Papers

Clinical Practice Guideline for the Managem... 2002 2026 2010 2018 2.5k
  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (2015)
    Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases
  2. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America (2009)
    Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases
  3. Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases (2005)
    Maureen Roden, Theoklis E. Zaoutis et al. Clinical Infectious Diseases
  4. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America (2008)
    Thomas J. Walsh, Elias Anaissie et al. Clinical Infectious Diseases
  5. Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus (2002)
    Sibel Aşçıoğlu, John Rex et al. Clinical Infectious Diseases
  6. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America (2016)
    Thomas F. Patterson, George R. Thompson et al. Clinical Infectious Diseases
  7. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia (2007)
    Oliver A. Cornely, Johan Maertens et al. New England Journal of Medicine
  8. Guidelines for Treatment of Candidiasis (2004)
    Peter G. Pappas, John Rex et al. Clinical Infectious Diseases
  9. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (2016)
    Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases
  10. Epidemiology and Clinical Manifestations of Mucormycosis (2012)
    G. Petrikkos, Anna Skiada et al. Clinical Infectious Diseases
  11. Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia (1999)
    Thomas J. Walsh, Robert W. Finberg et al. New England Journal of Medicine
  12. Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections (1997)
    John Rex, Michael A. Pfaller et al. Clinical Infectious Diseases
  13. Practice Guidelines for the Treatment of Candidiasis (2000)
    John Rex, Thomas J. Walsh et al. Clinical Infectious Diseases
  14. Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia (2004)
    Thomas J. Walsh, Hedy Teppler et al. New England Journal of Medicine
  15. The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis (2005)
    Theoklis E. Zaoutis, Junhao Chu et al. Clinical Infectious Diseases
  16. Anidulafungin versus Fluconazole for Invasive Candidiasis (2007)
    Annette C. Reboli, Coleman Rotstein et al. New England Journal of Medicine
  17. Practice Guidelines for Diseases Caused by Aspergillus (2000)
    D. A. Stevens, V L Kan et al. Clinical Infectious Diseases
  18. Infections Caused byScedosporiumspp (2008)
    Karoll J. Cortez, Emmanuel Roilides et al. Clinical Microbiology Reviews
  19. Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation (2004)
    V. Ratanatharathorn, Daniel E. Stepan et al. Clinical Infectious Diseases
  20. Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections (2003)
    John R. Perfect, Kieren A. Marr et al. Clinical Infectious Diseases
  21. Human Rhinoviruses (2013)
    Samantha E. Jacobs, Daryl M. Lamson et al. Clinical Microbiology Reviews
  22. Pathogenesis of Mucormycosis (2012)
    Ashraf S. Ibrahim, Brad Spellberg et al. Clinical Infectious Diseases
  23. Combination Antifungal Therapy for Invasive Aspergillosis (2015)
    Kieren A. Marr, Haran T. Schlamm et al. Annals of Internal Medicine

Immediate Impact

12 by Nobel laureates 12 from Science/Nature 124 standout
Sub-graph 1 of 20

Citing Papers

Macromolecular condensation organizes nucleolar sub-phases to set up a pH gradient
2024 Standout
The importance of antimicrobial resistance in medical mycology
2022 Standout
159 intermediate papers

Works of Thomas J. Walsh being referenced

Combination Antifungal Therapy for Invasive Aspergillosis
2015 Standout
Detection of Galactomannan Antigenemia by Enzyme Immunoassay for the Diagnosis of Invasive Aspergillosis: Variables That Affect Performance
2004
and 131 more

Author Peers

Author Last Decade Papers Cites
Thomas J. Walsh 46980 38757 6152 6271 760 61.8k
David W. Denning 41067 32578 7134 3197 713 53.5k
Michael A. Pfaller 48434 37065 3536 3080 819 66.4k
Dimitrios P. Kontoyiannis 28858 23942 3875 3960 600 37.6k
David A. Stevens 22800 20695 3958 2545 769 39.4k
Kieren A. Marr 23604 20579 2992 3693 219 30.6k
Jacques F. Meis 24226 19999 3409 1467 670 32.7k
John R. Perfect 23548 23430 1893 2182 433 33.1k
Mihai G. Netea 21374 19870 1082 4109 1.0k 73.2k
Ronald N. Jones 24973 20243 1384 1677 1.3k 55.3k
Daniel J. Diekema 22217 16767 1516 1257 349 30.0k

All Works

Loading papers...

Rankless by CCL
2026